Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.49 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.47 |
| ▸ | SCN1A | P35498 | 1/20 | 0.46 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.46 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11856164 | 0.89 | CA1 (0.50) | TSHRMAPTALDH1A1RAB9APOLB | |
| SCHEMBL11856189 | 0.81 | TSHR (0.52) | TSHRMAPTALDH1A1POLBKMT2A | |
| SCHEMBL12274416 | 0.81 | TDP1 (0.65) | LMNAMAPTALDH1A1NPC1RAB9A | |
| SCHEMBL42732 | 0.80 | CA1 (0.64) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL28544329 | 0.79 | LMNA (0.50) | LMNACYP1A2CYP3A4MAOATSHR | |
| Bromide SCHEMBL28362093 | 0.79 | CA1 (0.63) | LMNACYP1A2TSHRCYP2C19MAPT | |
| SCHEMBL14345052 | 0.79 | ALDH1A1 (0.65) | LMNATSHRMAPTALDH1A1NPC1 | |
| SCHEMBL13391182 | 0.79 | ALDH1A1 (0.69) | LMNACYP1A2CYP3A4MAOATSHR | |
| SCHEMBL640638 | 0.78 | TSHR (0.64) | LMNACYP3A4TSHRMAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL8359634 | 0.78 | CA1 (0.61) | LMNACYP1A2CYP3A4MAOATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100093747-A1 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS | CELTAXSYS, INC. | 2010-04-15 | — | — | US | disclosed |
| EP-0922699-B1 | Asymmetric stilbene compounds useful as sun protection agents | CIBA SC HOLDING AG (CH) | 2004-11-17 | — | — | EP | disclosed |
| US-6482241-B1 | Asymmetric stilbene compounds | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-11-19 | — | — | US | disclosed |
| US-6143889-A | Asymmetric stilbene compounds | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-11-07 | — | — | US | disclosed |
| EP-0922699-A1 | Asymmetric stilbene compounds useful as sun protection agents | Ciba SC Holding AG (CH) | 1999-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093747-A1 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS | PMAIP1, CDC42, DCX | LMNA 3765/4885CYP1A2 4827/4885CYP3A4 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.